Abstract
Background: Due to low incidence, rhabdomyosarcoma (RMS) of the biliary tract poses numerous
complex management problems especially in diagnosis and local therapy.
Patients: The two presented patients were diagnosed by biopsy, performed by laparotomy and
endoscopic retrograde cholangiopancreatography (ERCP) respectively. Nearly complete
tumor regression was achieved by chemotherapy and irradiation according to the CWS-protocol.
Subsequent radical resection followed directly in one patient and after local relapse
in the other. Both patients are in remission 13 resp. 4 years after diagnosis with
a good quality of life.
Conclusions: Even in well responding biliary rhabdomyosarcomas, surgery after chemotherapy and
radiotherapy seems to be necessary. Adjuvant chemotherapy should be continued after
hepatic lobectomy.
Zusammenfassung
Hintergrund: Das Rhabdomyosarkom der Gallengänge ist sehr selten und stellt besondere Anforderungen
an die Diagnostik und Lokaltherapie.
Patienten: Die histologische Diagnose unserer beiden Patienten erfolgte nach Probelaparotomie
bzw. endoskopischer retrograder Cholangiopankreatikografie (ERCP). Die neoadjuvante
Chemo- und Strahlentherapie entsprechend dem CWS-Protokoll führte zur partiellen bzw.
subtotalen Tumorregression. Der erste Patient wurde anschließend radikal reseziert,
die zweite Patientin erst nach lokalem Rückfall. Beide Patienten berichten von einer
guten Lebensqualität bei einem Langzeitüberleben von 13 bzw. 4 Jahren.
Schlussfolgerungen: Die Resektion von Resttumoren erscheint notwendig. Postoperativ sollte eine adjuvante
Chemotherapie protokollgemäß fortgesetzt werden.
Key words
rhabdomyosarcoma of the biliary tract - long term survival
Schlüsselwörter
Rhabdomyosarkom der Gallengänge - Langzeitüberleben
Literatur
1
Bernbeck B, Bahci S, Meisel R.
Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide
(TECC) followed by autologous hematopoietic stem cell support in patients with high
risk soft tissue sarcoma (STS).
Klin Pädiatr.
2007;
219
318-322
2
Calaminus G, Weinspach S, Teske C.
Quality of survival in children and adolescents after treatment for chilhood cancer:
the influence of reported late effects on health related quality of life.
Klin Pädiatr.
2007;
219
152-157
3
Callea F, Bonetti M, Medicina D. et al .
Hepatic tumor-like lesions in childhood.
J Surg Oncol Suppl.
1993;
3
170-172
4
Donnelly LF, Bisset GS, Frush DP.
Diagnosis please. Case 2: Embryonal rhabdomyosarcoma of the biliary tree.
Radiology.
1998;
208
621-623
5
Herold R, Reiche R, Creutzig U.
Stand und Bewertung der Strukturen und Ausstattung pädiatrisch-onkologisch-hämatologischer
Kliniken.
Klin Pädiatr.
2007;
219
380-390
6
Hunt GC, Corless CL, Terry AB. et al .
Embryonal rhabdomyosarcoma in a 3-year-old child diagnosed at ERCP: case report and
review.
Gastrointest Endosc.
2002;
56
445-447
7
Ruymann FB, Raney RB, Crist WM. et al .
Rhabdomyosarcoma of the biliary tree in childhood. A report from the Intergroup Rhabdomyosarcoma
study.
Cancer.
1985;
56
575-581
8
Schweizer P, Schweizer M, Wehrmann M.
Major resection for embryonal rhabdomyosarcoma of the biliary tree.
Pediatr Surg Int.
1994;
9
268-273
9
Spunt SL, Lobe TE, Pappo AS. et al .
Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma.
J Ped Surg.
2000;
35
309-316
10
Tireli GA, Sander S, Dervisoglu S. et al .
Embryonal rhabdomyosarcoma of the common bile duct mimicking choledochal cyst.
J Hepatobiliary Pancreat Surg.
2005;
12
263-265
11 Treuner J, Koscielniak E. et al .German Cooperative Soft Tissue Sarcoma Study.
In: Treatment protocols of the Gesellschaft für Pädiatrische Onkologie und Hämatologie
(GPOH) . 1996 and 1991
Correspondence
Julia HuberMD
Division of Pediatric Hematology/Oncology
Department of Pediatrics and Adolescent Medicine
Medical University Graz
Auenbruggerplatz 30
8036 Graz
Austria
Phone: +43/316/385/34 85
Fax: +43/316/385/34 50
Email: julia.huber@meduni-graz.at